Difference between revisions of "Team:Peking/Demonstrate"

Line 277: Line 277:
 
                                 color:#11abb0;
 
                                 color:#11abb0;
 
                             }
 
                             }
 +
                        p a:hover{
 +
                            color:#4d7d75;
 +
                        }
 
                         </style>
 
                         </style>
 
                          
 
                          
Line 284: Line 287:
 
             <a id="Project"></a>
 
             <a id="Project"></a>
 
                             <div class="texttitle">What we have done in the project</div>
 
                             <div class="texttitle">What we have done in the project</div>
−
                                 <p class="lead add-bottom" style="color:#5E5656">Constructed a multifunctional protein sequences of interest via molecular biological methods, and introduced the constructed plasmids into the engineered bacteria for protein expression.<a href="#"/>(Learn more)</a></p>
+
                                 <p class="lead add-bottom" style="color:#5E5656">1. Constructed a multifunctional protein sequences of interest via molecular biological methods, and introduced the constructed plasmids into the engineered bacteria for protein expression.<a href="#"/>(Learn more)</a></p>
 
                              
 
                              
 
                              
 
                              

Revision as of 10:35, 15 October 2016

Recovery

Recovery.

What we have done in the project

1. Constructed a multifunctional protein sequences of interest via molecular biological methods, and introduced the constructed plasmids into the engineered bacteria for protein expression.(Learn more)

Design


References:

[1] Christopher, D. et al. Streptavidin–biotin technology: improvements and innovations in chemical and biological applications. Appl Microbiol Biotechnol 97, 9343–9353 (2013).

[2] Sau-Ching, W. et al. Engineering monomeric streptavidin and its ligands with infinite affinity in binding but reversibility in interaction. Proteins 77, 404-412 (2009).